Novel anti-adipogenic activity produced by human fibroblasts.

Fatty tissue is generally found in distinct "depots" distributed throughout the human body. Adipocytes from each of the various depots differ in their metabolic capacities and their responses to environmental stimuli. Although a general understanding of the factors responsible for adipogenic transformation has been achieved, much is not understood about the mechanisms of adipose tissue deposition and the phenotypes of the adipocytes found within each depot. A clue to the factors regulating fat deposition may come from studies of adipogenesis using primary human orbital fibroblasts from patients with thyroid eye disease, a condition in which intense inflammation leads to expansion of orbital adipose tissue via differentiation of fibroblasts to adipocytes. We have previously demonstrated that adipogenesis of orbital fibroblasts is negatively correlated with cellular expression of the Thy-1 surface marker. In this study, we developed a novel imaging flow cytometric approach for the assessment of adipogenesis to test the hypothetical dependence of adipogenic potential on lack of Thy-1 expression. Using this technique, we learned that Thy-1-positive fibroblasts are, in fact, capable of differentiating into adipocytes but are less likely to do so because they secrete a paracrine anti-adipogenic factor. It is possible that such a factor plays an important role in the prevention of excess fat deposition in the normal orbit and may even be exploited as a therapy for the treatment of obesity, a major worldwide health concern.

[1]  A Tremblay,et al.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.

[2]  S. Grundy,et al.  Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy. , 1992, The Journal of clinical endocrinology and metabolism.

[3]  Terry J. Smith,et al.  Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. , 2002, The Journal of clinical endocrinology and metabolism.

[4]  Seema Kumar,et al.  Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy. , 2008, Thyroid : official journal of the American Thyroid Association.

[5]  Tom Britton,et al.  Dynamics of fat cell turnover in humans , 2008, Nature.

[6]  A. Tchernof,et al.  Androgens and body fat distribution , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  J. Hagood,et al.  Thy‐1 as a regulator of cell‐cell and cell‐matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  R. Wing,et al.  Successful weight loss maintenance. , 2003, Annual review of nutrition.

[9]  A. Dunaif,et al.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.

[10]  S. Feldon,et al.  Regulation of Lymphocyte Function by PPARγ: Relevance to Thyroid Eye Disease-Related Inflammation , 2008, PPAR research.

[11]  Ling Zheng,et al.  Effects of androgen therapy on adipose tissue and metabolism in older men. , 2004, The Journal of clinical endocrinology and metabolism.

[12]  M. Dieudonné,et al.  Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. , 1998, American journal of physiology. Cell physiology.

[13]  R. Phipps,et al.  Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts. , 2001, The American journal of pathology.

[14]  C. Gorman,et al.  Pathogenesis of Graves' ophthalmopathy. , 1989, Developments in ophthalmology.

[15]  T. J. Smith,et al.  Insights into the role of fibroblasts in human autoimmune diseases , 2005, Clinical and experimental immunology.

[16]  Terry J. Smith,et al.  Isolation and phenotypic characterization of lung fibroblasts. , 2005, Methods in molecular medicine.

[17]  Terry J. Smith,et al.  Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy. , 2002, Archives of ophthalmology.

[18]  B. Spiegelman,et al.  Adipogenesis and Obesity: Rounding Out the Big Picture , 1996, Cell.

[19]  Terry J. Smith,et al.  T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy. , 2006, Endocrinology.

[20]  G. H. Watson,et al.  Direct effects of sex steroid hormones on adipose tissues and obesity , 2004, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[21]  S. Rodriguez-Cuenca,et al.  Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu. , 2005, American journal of physiology. Endocrinology and metabolism.

[22]  M. Dieudonné,et al.  Opposite Effects of Androgens and Estrogens on Adipogenesis in Rat Preadipocytes: Evidence for Sex and Site-Related Specificities and Possible Involvement of Insulin-Like Growth Factor 1 Receptor and Peroxisome Proliferator-Activated Receptorγ 21. , 2000, Endocrinology.

[23]  J. Kral,et al.  Identification of estrogen receptor beta RNA in human breast and abdominal subcutaneous adipose tissue. , 1998, Biochemical and biophysical research communications.

[24]  Terry J. Smith,et al.  Fibroblast subsets in the human orbit: Thy‐1+ and Thy‐1‐ subpopulations exhibit distinct phenotypes , 2002, European journal of immunology.

[25]  J. Massagué,et al.  Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Ross,et al.  Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: anthropometric relationships. , 1994, The American journal of clinical nutrition.

[27]  B. Graf,et al.  Fibroblasts as sentinel cells: role of the CDcd40-CDcd40 ligand system in fibroblast activation and lung inflammation and fibrosis. , 2001, Chest.

[28]  Terry J. Smith,et al.  Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production. , 1998, American journal of physiology. Cell physiology.

[29]  K. Preissner,et al.  Human Thy-1 (CD90) on Activated Endothelial Cells Is a Counterreceptor for the Leukocyte Integrin Mac-1 (CD11b/CD18)1 , 2004, The Journal of Immunology.

[30]  G. Serrero,et al.  Inhibition of adipose differentiation by 9α, 11β-prostaglandin F2α , 1993 .

[31]  S. Feldon,et al.  Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. , 2006, The American journal of pathology.

[32]  A. Vidal-Puig,et al.  Thematic review series: Adipocyte Biology. Adipose tissue function and plasticity orchestrate nutritional adaptation Published, JLR Papers in Press, March 20, 2007. , 2007, Journal of Lipid Research.

[33]  J. Després,et al.  Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[34]  S. Trokel,et al.  Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. , 1981, Ophthalmology.

[35]  S. Spinelli,et al.  Platelets as a Novel Target for PPARγ Ligands , 2012, BioDrugs.

[36]  A. Tchernof,et al.  Sex Steroid Hormones, Sex Hormone-Binding Globulin, and Obesity in Men and Women , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[37]  R. Looney,et al.  CD40 expression by human fibroblasts. , 1995, Clinical immunology and immunopathology.

[38]  Donald C. Chang,et al.  Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy. , 2005, Investigative ophthalmology & visual science.

[39]  G. Sempowski,et al.  Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. , 1995, The Journal of clinical endocrinology and metabolism.

[40]  S. Nagataki,et al.  Premature fat deposition in the salivary glands associated with Sjögren syndrome: MR and CT evidence. , 1997, AJNR. American journal of neuroradiology.

[41]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[42]  Terry J. Smith,et al.  Immune mechanisms in thyroid eye disease. , 2008, Thyroid : official journal of the American Thyroid Association.

[43]  T. Price,et al.  Identification of progesterone receptor in human subcutaneous adipose tissue. , 1998, The Journal of clinical endocrinology and metabolism.

[44]  P. Rubin,et al.  The pathophysiology of thyroid-associated ophthalmopathy. , 2002, Ophthalmology clinics of North America.

[45]  M. Ritter,et al.  Association of Thy-1 cell surface differentiation antigen with certain connective tissues in vivo , 2004, Cell and Tissue Research.

[46]  G. Tsujimoto,et al.  Microarray evaluation of EP4 receptor-mediated prostaglandin E2 suppression of 3T3-L1 adipocyte differentiation. , 2004, Biochemical and biophysical research communications.

[47]  A. Saalbach,et al.  Detection of human soluble Thy-1 in serum by ELISA , 1999, Cell and Tissue Research.

[48]  R. Looney,et al.  Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. , 1994, Clinical immunology and immunopathology.

[49]  H. Kurachi,et al.  Identification of estrogen receptor in human adipose tissue and adipocytes. , 1994, The Journal of clinical endocrinology and metabolism.

[50]  Terry J. Smith,et al.  Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. , 2003, The American journal of pathology.

[51]  Terry J. Smith,et al.  Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. , 1997, The American journal of pathology.

[52]  M. Boyanov,et al.  Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency , 2003, The aging male : the official journal of the International Society for the Study of the Aging Male.

[53]  Steven B Heymsfield,et al.  Waist circumference and abdominal adipose tissue distribution: influence of age and sex. , 2005, The American journal of clinical nutrition.

[54]  K. Clément,et al.  Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. , 2007, Endocrinology.

[55]  S. Staibano,et al.  Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy. , 2004, Journal of molecular endocrinology.